Literature DB >> 23591725

Ambulatory blood pressure monitoring in children and adolescents: coming of age?

Empar Lurbe1, María Isabel Torró, Julio Alvarez.   

Abstract

Over the last years, ambulatory blood pressure monitoring has been introduced into the pediatric population, contributing to a significant increase in the bulk of knowledge of crucial clinically relevant issues. Guidelines have established the currently known conditions where ambulatory blood pressure monitoring is useful and where it will provide additional information in children and adolescents. How common and important the intra-individual differences are within clinical and ambulatory blood pressure is the keystone to the use of ambulatory blood pressure monitoring as a diagnostic tool. By using not only office, but also ambulatory blood pressure, four possible situations arise. Two of these have values in agreement for normotension or hypertension. Two have values that are discrepant. The latter two are known as white coat and masked hypertension. The relationship with hypertension-induced organ damage, the prognostic value and the assessment of treatment goals are key issues of ambulatory blood pressure monitoring. In children, the accurate identification of hypertension at the earliest possible age would, therefore, give health-care providers the opportunity to initiate preventive measures, thereby reducing the chance of developing end-organ damage and its attendant morbidity and mortality.

Entities:  

Mesh:

Year:  2013        PMID: 23591725     DOI: 10.1007/s11906-013-0350-7

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  58 in total

1.  Clinical and research aspects of ambulatory blood pressure monitoring in children.

Authors:  Empar Lurbe; Jonathon M Sorof; Stephen R Daniels
Journal:  J Pediatr       Date:  2004-01       Impact factor: 4.406

2.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

3.  Masked hypertension in young patients after successful aortic coarctation repair: impact on left ventricular geometry and function.

Authors:  G Di Salvo; B Castaldi; L Baldini; S Gala; F del Gaizo; A D'Andrea; G Limongelli; A F D'Aiello; G Scognamiglio; B Sarubbi; G Pacileo; M G Russo; R Calabrò
Journal:  J Hum Hypertens       Date:  2011-01-13       Impact factor: 3.012

4.  Influence of diurnal blood pressure variations on target organ abnormalities in adolescents with mild essential hypertension.

Authors:  C W Belsha; T G Wells; K L McNiece; P M Seib; J K Plummer; P L Berry
Journal:  Am J Hypertens       Date:  1998-04       Impact factor: 2.689

5.  Factors affecting left ventricular mass in childhood: the Muscatine Study.

Authors:  D D Malcolm; T L Burns; L T Mahoney; R M Lauer
Journal:  Pediatrics       Date:  1993-11       Impact factor: 7.124

6.  Prevalence, persistence, and clinical significance of masked hypertension in youth.

Authors:  Empar Lurbe; Isabel Torro; Vicente Alvarez; Tim Nawrot; Rafael Paya; Josep Redon; Jan A Staessen
Journal:  Hypertension       Date:  2005-03-14       Impact factor: 10.190

7.  White coat effect and white coat hypertension in pediatric patients.

Authors:  Seiji Matsuoka; Ken Kawamura; Masataka Honda; Midori Awazu
Journal:  Pediatr Nephrol       Date:  2002-10-29       Impact factor: 3.714

8.  Ambulatory blood pressure in hypertensive patients with autosomal dominant polycystic kidney disease.

Authors:  T C Li Kam Wa; A M Macnicol; M L Watson
Journal:  Nephrol Dial Transplant       Date:  1997-10       Impact factor: 5.992

9.  Diurnal blood-pressure variations in haemodialysis and CAPD patients.

Authors:  A J Luik; D G Struijk; U Gladziwa; R W von Olden; J P von Hooff; P W de Leeuw; K M Leunissen
Journal:  Nephrol Dial Transplant       Date:  1994       Impact factor: 5.992

10.  Strict blood-pressure control and progression of renal failure in children.

Authors:  Elke Wühl; Antonella Trivelli; Stefano Picca; Mieczyslaw Litwin; Amira Peco-Antic; Aleksandra Zurowska; Sara Testa; Augustina Jankauskiene; Sevinc Emre; Alberto Caldas-Afonso; Ali Anarat; Patrick Niaudet; Sevgi Mir; Aysin Bakkaloglu; Barbara Enke; Giovanni Montini; Ann-Margret Wingen; Peter Sallay; Nikola Jeck; Ulla Berg; Salim Caliskan; Simone Wygoda; Katharina Hohbach-Hohenfellner; Jiri Dusek; Tomasz Urasinski; Klaus Arbeiter; Thomas Neuhaus; Jutta Gellermann; Dorota Drozdz; Michel Fischbach; Kristina Möller; Marianne Wigger; Licia Peruzzi; Otto Mehls; Franz Schaefer
Journal:  N Engl J Med       Date:  2009-10-22       Impact factor: 91.245

View more
  3 in total

1.  Diagnosis and management of white-coat hypertension in children and adolescents: A Midwest Pediatric Nephrology Consortium study.

Authors:  Yosuke Miyashita; Joseph T Flynn; Coral D Hanevold
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-07-23       Impact factor: 3.738

Review 2.  Pharmacologic Management of Pediatric Hypertension.

Authors:  Jason Misurac; Kristen R Nichols; Amy C Wilson
Journal:  Paediatr Drugs       Date:  2016-02       Impact factor: 3.022

3.  Clinical and Immunological Profile of Anti-factor H Antibody Associated Atypical Hemolytic Uremic Syndrome: A Nationwide Database.

Authors:  Mamta Puraswani; Priyanka Khandelwal; Himanshi Saini; Savita Saini; Bahadur Singh Gurjar; Aditi Sinha; Rajashri Pramod Shende; Tushar Kanti Maiti; Abhishek Kumar Singh; Uma Kanga; Uma Ali; Indira Agarwal; Kanav Anand; Narayan Prasad; Padmaraj Rajendran; Rajiv Sinha; Anil Vasudevan; Anita Saxena; Sanjay Agarwal; Pankaj Hari; Arvind Sahu; Satyajit Rath; Arvind Bagga
Journal:  Front Immunol       Date:  2019-06-07       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.